Bridging the gap to commercial scale in bio-based industries

The potential of bio-based chemicals, ingredients, and materials to transform industries and create a more sustainable future is clear. 

Yet, turning scientific breakthroughs into commercially viable solutions remains a complex challenge. No single entity can achieve this alone; it requires a collaborative effort among bio-developers, chemical manufacturers, brands, investors, enablers, and suppliers.

This collective effort takes center stage at Bio Innovations Europe 2026, set for 10–11 June in The Hague. 

The event aims to fast-track the journey from innovation to large-scale industrial deployment by tackling the critical questions facing the sector today. How do we close the funding gap for biorefinery scale-up? How can the chemical industry transition from fossil to bio at an industrial level? What strategies will ensure a smooth shift from lab to factory without stalling progress? And how can we make bio-based products mainstream for brands and consumers alike?

Addressing these challenges requires more than just discussion: it calls for meaningful partnerships. That’s why the event features high-value, pre-arranged one-on-one meetings designed to connect innovators with investors, suppliers, and potential customers. 

With over 400 bio-pioneers in attendance, the event offers a unique environment to grow your business development pipeline, source innovative solutions, secure investments, and accelerate scaling efforts.

Secure your place today and ensure you’re in the room with the key players shaping the future of bio-based industries. 

For more information or to explore opportunities as a delegate, speaker, or sponsor, contact Paul at Paul@worldbiomarkets.com. 

Learn more about Bio Innovations Europe here.

The nova-Institute is a headline partner of Bio Innovations Europe and actively supports the event by contributing its expertise in renewable carbon and defossilisation strategies.

Source

Bio Innovations Europe, original text, 2026-05-04.

Supplier

nova-Institut GmbH
World Bio Market Insights

Share